Lupin rises on collaborating with American College of Gastroenterology

20 Dec 2019 Evaluate

Lupin is currently trading at Rs. 772.50, up by 1.80 points or 0.23% from its previous closing of Rs. 770.70 on the BSE.

The scrip opened at Rs. 771.10 and has touched a high and low of Rs. 777.25 and Rs. 769.00 respectively. So far 12956 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 887.70 on 04-Feb-2019 and a 52 week low of Rs. 646.20 on 07-Oct-2019.

Last one week high and low of the scrip stood at Rs. 777.25 and Rs. 745.30 respectively. The current market cap of the company is Rs. 34971.64 crore.

The promoters holding in the company stood at 46.96%, while Institutions and Non-Institutions held 38.99% and 14.05% respectively.

Lupin has collaborated with the American College of Gastroenterology (ACG) for a new initiative ‘The Best of ACG’. Under the terms of the agreement, ACG will take the best education materials from the ACG conference and will present it in Kolkata, Bangalore and Delhi in January 2020. Through this initiative, Lupin aims to bring in global educational material and provide access to latest developments in the field of gastroenterology in India.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.



Lupin Share Price

1530.95 -53.00 (-3.35%)
04-Jun-2024 12:33 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1423.80
Dr. Reddys Lab 5664.80
Cipla 1439.75
Zydus Lifesciences 955.85
Lupin 1530.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.